However, clinical studies have shown promising results: Average Weight Loss: Clinical trials indicate that people using GLP-1 for weight loss typically lose around 15-20% of their body weight over a period of 68 weeks (approximately 1 year and 3 months), when combined with a reduced-calorie diet and increased physical activity
Always consult a healthcare provider to ensure any new supplement fits your specific health profile
Semaglutide GLP-1 is usually prescribed at its lowest dosage and gradually increases as the patients body adjusts to the medication, with the goal of minimizing side effects
Our team responds within one business hour during office hours
DISCUSSION In this study, the weight loss response to semaglutide differed between postmenopausal women with and without HT use
For example, pharmacists were seeing Saxenda, Wegovy, and Zepbound being prescribed for patients who did not have a body mass index (BMI) of 30 kg/m2 or a BMI of 27 kg/m2 with at least one weight associated comorbidity